5314 related articles for article (PubMed ID: 11861215)
1. The role of human papillomaviruses in human cancers.
Münger K
Front Biosci; 2002 Mar; 7():d641-9. PubMed ID: 11861215
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of carcinogenesis by human papillomavirus-16.
Ishiji T
J Dermatol; 2000 Feb; 27(2):73-86. PubMed ID: 10721654
[TBL] [Abstract][Full Text] [Related]
4. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
5. Papillomaviruses in human cancers.
zur Hausen H
Proc Assoc Am Physicians; 1999; 111(6):581-7. PubMed ID: 10591087
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
Rosales R; López-Contreras M; Cortes RR
J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
[TBL] [Abstract][Full Text] [Related]
7. [Human papillomaviruses, cell cycle and cervical cancer].
Mougin C; Humbey O; Gay C; Riethmuller D
J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):13-20. PubMed ID: 10675829
[TBL] [Abstract][Full Text] [Related]
8. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
9. Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options.
Brown RE; Naqvi S; McGuire MF; Buryanek J; Karni RJ
J Otolaryngol Head Neck Surg; 2017 Aug; 46(1):52. PubMed ID: 28818106
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells.
Wells SI; Aronow BJ; Wise TM; Williams SS; Couget JA; Howley PM
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7093-8. PubMed ID: 12756294
[TBL] [Abstract][Full Text] [Related]
11. Human papillomaviruses.
zur Hausen H; de Villiers EM
Annu Rev Microbiol; 1994; 48():427-47. PubMed ID: 7826013
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic activities of human papillomaviruses.
McLaughlin-Drubin ME; Münger K
Virus Res; 2009 Aug; 143(2):195-208. PubMed ID: 19540281
[TBL] [Abstract][Full Text] [Related]
13. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.
von Knebel Doeberitz M
Eur J Cancer; 2002 Nov; 38(17):2229-42. PubMed ID: 12441259
[TBL] [Abstract][Full Text] [Related]
14. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus infection of non-melanoma skin cancers in immunocompetent hosts.
Biliris KA; Koumantakis E; Dokianakis DN; Sourvinos G; Spandidos DA
Cancer Lett; 2000 Dec; 161(1):83-8. PubMed ID: 11078916
[TBL] [Abstract][Full Text] [Related]
16. The role of human papillomaviruses in oncogenesis.
Mighty KK; Laimins LA
Recent Results Cancer Res; 2014; 193():135-48. PubMed ID: 24008297
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.
Cerasuolo A; Annunziata C; Tortora M; Starita N; Stellato G; Greggi S; Maglione MG; Ionna F; Losito S; Botti G; Buonaguro L; Buonaguro FM; Tornesello ML
Oncotarget; 2017 May; 8(21):34070-34081. PubMed ID: 28423662
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
19. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
Münger K; Scheffner M; Huibregtse JM; Howley PM
Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells.
Hiraiwa A; Kiyono T; Segawa K; Utsumi KR; Ohashi M; Ishibashi M
Virology; 1993 Jan; 192(1):102-11. PubMed ID: 8390746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
